Profile data is unavailable for this security.
About the company
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.
- Revenue in USD (TTM)301.51bn
- Net income in USD3.00bn
- Incorporated1994
- Employees45.00k
- LocationMckesson Corp6555 State Highway 161IRVING 75039United StatesUSA
- Phone+1 (972) 446-4800
- Fax+1 (302) 636-5454
- Websitehttps://www.mckesson.com/
Mergers & acquisitions
| Acquired company | MCK:NYQ since announced | Transaction value |
|---|---|---|
| Compile Inc | 12.42% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 1.46bn | 414.67m | 18.35bn | 2.79k | 44.26 | 9.27 | -- | 12.54 | 4.98 | 4.98 | 17.57 | 23.76 | 0.6354 | 1.74 | 13.24 | 3,800,528.00 | 18.30 | 18.82 | 22.61 | 23.91 | 45.77 | 46.55 | 28.81 | 27.98 | 4.02 | -- | 0.0898 | 36.49 | 15.69 | 16.11 | 13.15 | 19.60 | 13.83 | 31.06 |
| Cardinal Health Inc | 216.15bn | 639.00m | 25.25bn | 48.00k | 40.85 | -- | 18.86 | 0.1168 | 2.54 | 2.54 | 856.88 | -14.14 | 4.75 | 11.70 | 18.63 | 4,503,084.00 | 1.41 | -1.13 | 6.56 | -3.08 | 3.34 | 4.00 | 0.2966 | -0.2816 | 0.5017 | 31.29 | 3.70 | -- | 13.04 | 8.43 | 127.97 | -- | 4.61 | 1.40 |
| Cencora Inc | 271.58bn | 1.87bn | 47.83bn | 42.00k | 26.11 | 52.45 | 16.25 | 0.1761 | 9.18 | 9.18 | 1,334.79 | 4.57 | 4.43 | 14.81 | 12.64 | 6,466,177.00 | 3.03 | 0.9542 | 13.95 | 3.95 | 3.37 | 3.14 | 0.6847 | 0.2178 | 0.5162 | 11.93 | 0.8183 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
| McKesson Corp | 301.51bn | 3.00bn | 70.95bn | 45.00k | 24.46 | -- | 18.71 | 0.2353 | 22.07 | 22.07 | 2,223.50 | -15.67 | 4.67 | 13.56 | 13.83 | 6,700,134.00 | 4.89 | 0.6349 | 21.92 | 2.21 | 4.01 | 5.04 | 1.05 | 0.1611 | 0.4959 | 15.38 | 1.40 | 144.13 | 4.83 | 5.84 | 218.41 | -- | -0.7704 | 10.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 11.57m | 8.81% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 6.99m | 5.32% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 6.32m | 4.81% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 5.02m | 3.82% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 3.38m | 2.57% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.54m | 1.93% |
| Viking Global Investors LPas of 31 Dec 2023 | 2.23m | 1.70% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.21m | 1.68% |
| Putnam Investment Management LLCas of 31 Dec 2023 | 2.00m | 1.52% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2023 | 1.66m | 1.26% |
